GlassScriptPhysician profile
Gary Kocharian
NPI 1457857948
$5,210.54
in general payments reported to CMS, 2019-2025
12 companies · $4,271 in 2025
The $4,271 reported for 2025 was more than what 79% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $940 · 2025: $4,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,071 · Travel and Lodging: $2,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,070.80 |
| Travel and Lodging | $2,139.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,805.23 | 2024-2025 | Surpass Evolve, Neuroform Ez 3, Neuroform Atlas |
| Globus Medical, INC. | $1,634.37 | 2025 | Excelsius Gps, Senza, Attrax |
| Penumbra, INC. | $594.76 | 2024-2025 | Red 72, Penumbra Coil 400, Penumbra System |
| Depuy Synthes Sales INC. | $293.86 | 2025 | Velys, Viper, Teligen |
| Balt USA, LLC | $226.75 | 2025 | Raptor Aspiration Catheter |
| Saluda Medical Americas, INC. | $200.50 | 2025 | Evoke |
| Aesculap, INC. | $150.14 | 2024 | Progav 2.0 |
| Microvention, INC. | $111.59 | 2025 | Stent, Web Aneurysm Embolization System, Sofia 6f-131cm Str |
| Medical Device Business Services, INC. | $65.79 | 2025 | Velys |
| Route 92 Medical, INC. | $60.66 | 2025 | |
| Cerapedics INC. | $41.37 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Carlsmed, INC. | $25.52 | 2025 | Aprevo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Kocharian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.